Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

Erminia Massarelli(The University of Texas MD Anderson Cancer Center), Heather Lin(The University of Texas MD Anderson Cancer Center), Lawrence E. Ginsberg(The University of Texas MD Anderson Cancer Center), Hai T. Tran(The University of Texas MD Anderson Cancer Center), J.J. Lee(The University of Texas MD Anderson Cancer Center), Jaime Rodriguez Canales(The University of Texas MD Anderson Cancer Center), Michelle D. Williams(The University of Texas MD Anderson Cancer Center), George R. Blumenschein(The University of Texas MD Anderson Cancer Center), Charles Lu(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), M.S. Kies(The University of Texas MD Anderson Cancer Center), V. Papadimitrakopoulou(The University of Texas MD Anderson Cancer Center)
Annals of Oncology
May 30, 2015
10.1093/annonc/mdv194
Cited by 85Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis